Hide Board Information

Show Board Information

FTSE Xinhua China Index XINC

Board Mod: Add me as mod

Asst Mods:

Last Post: 06/04/2012 2:03:31 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 3

FTSE Xinhua China Index (XINC) Stock Message Board

Find XINC Recent News, XINC Filings, XINC Stock Quote, XINC Stock Chart, XINC Research & Opinions Below

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

Be the first to post on FTSE Xinhua China Index XINC

Recent Articles

• Kohl's Welcomes Ashley Buchanan as CEO to Foster Growth
• State Street's $2.25 Billion Debt: Fostering Inclusion in Finance
• Faraday Future Reinvents Its Stock Symbol to Emphasize AI
• Golub Capital BDC Introduces Major $150 Million Note Offering
• HPH Sees Board Changes Amid Strategic Transformation
• Eastman Kodak's Strategic Pension Plan Move and Market Impact
• HPH Announces Leadership Transition and Future Focus
• SpaceX to Launch NASA's Dragonfly Mission to Titan
• Clairvest's New Partnership with Redstone Food Group
• Automotive Properties REIT Acquires Key Montreal Rental Properties
• Tim Draper Enthusiastically Predicts Bitcoin's Striking Rise
• Hennessy Advisors' ESG ETF to Transfer Listings to Nasdaq
• Agora, Inc. Sees Strategic Shifts Amid Financial Adjustments
• Hesai Group Announces Impressive Q3 2024 Financial Growth
• Creative Global Technology Holdings' Upcoming IPO Details
• Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
• Analyzing Woodward's Q4 Earnings and Future Outlook
• Blue Bird's Financial Performance in the Latest Earnings Report
• Central Garden & Pet Reports Strong Q4 Earnings Performance
• Central Garden & Pet's Strong Q4 Earnings Highlights
• Enanta Pharma's Earnings Report Highlights for Investors in 2024
• Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
• Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
• Leslie's Performance in Q4: Key Insights and Future Prospects
• Exploring Central Garden & Pet's Recent Earnings Performance
• Insights into Enanta Pharma's Q4 Earnings Performance
• Blue Bird's Q4 Earnings Report Reveals Key Insights
• NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
• Columbia Financial Appoints Matthew Smith as New COO
• Impact of Treasury Picks on Markets and Emerging Economies
• Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
• Zoom Communications Enhances Forecast Following Strong Q3 Results
• Leadership Transition at Kohl's: Kingsbury's Departure Announced
• Tempest Therapeutics to Showcase Innovations at Key Conference
• Travere Therapeutics Announces Key Upcoming Investor Conferences
• Tesla Stock Faces Market Challenges Amid California Proposals
• Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
• Zoom Communications Turns a Profit with Impressive Q3 Earnings
• First Capital, Inc. Declares New Quarterly Dividend for Investors
• Columbia Financial Welcomes New COO Matthew Smith Amid Changes
• Universal Health Realty Income Trust Boosts Quarterly Dividend
• Amazon Strengthens AI Alliances with Major Investment in Anthropic
• Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
• Woodward's Q4 Earnings Highlights and Future Outlook for Investors
• Blue Bird's Q4 Earnings: Performance Review and Insights
• Central Garden & Pet: Analyzing Quarterly Earnings Results
• Central Garden & Pet Q4 Earnings Show Surprising Results
• Semtech's Q3 Earnings Report Shows Promising Growth
• LanzaTech Expands Board for Future Growth with Energy Expert
• Zimmer Biomet Secures FDA Approval for Innovative Knee Implant